Skip to main content
Signal8

Alva Emily Peterson

SEC insider (Form 3/4/5 filer). CIK 0001738422. Director at Amneal Pharmaceuticals, Inc. (AMRX). 3 reported Form 4/5 transactions since Sep 2024; latest on May 6, 2025. Located in BRIDGEWATER, NJ.

Companies Alva Emily Peterson has filed insider reports for

  • Amneal Pharmaceuticals, Inc. (AMRX): Director
Alva Emily Peterson profile photo

Alva Emily Peterson

CIK: 0001738422

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)1 (33.3%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Amneal Pharmaceuticals, Inc. logo
AMRX

Amneal Pharmaceuticals, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Amneal Pharmaceuticals, Inc. logo
    AMRX

    Amneal Pharmaceuticals, Inc.

    May 6, 2025
    Award

    Restricted Stock Units

    Direct
    34.8K shares-
  • Amneal Pharmaceuticals, Inc. logo
    AMRX

    Amneal Pharmaceuticals, Inc.

    May 5, 2025
    Exercise
    Direct
    40.3K shares-
  • Amneal Pharmaceuticals, Inc. logo
    AMRX

    Amneal Pharmaceuticals, Inc.

    Mar 5, 2025
    Sale
    Direct
    80K shares at avg. $8.90$712K

1-3 of 3